Raymond James & Associates’s Sharps Compliance Corp SMED Stock Holding History
Bought
Maintained
Sold
Other funds holding SMED
WA
RA
GIM
NIM
SMH
Raymond James & Associates's SMED Position: Q2 2022 in Review
Raymond James & Associates sold out of Sharps Compliance Corp (SMED) in Q2 2022, closing a stake of 118,374 shares — an estimated $698K sold.
Raymond James & Associates first reported a position in SMED in Q4 2021 and held it in 2 quarters. The position peaked at $842K in Q4 2021. 67 funds tracked by Wall St. Rank hold SMED as of Q2 2022.
- Raymond James & Associates reported no remaining Sharps Compliance Corp position as of Q2 2022 after selling out during the quarter.
- Raymond James & Associates sold 118,374 Sharps Compliance Corp shares in Q2 2022, an estimated $698K.
- Raymond James & Associates first reported a position in Sharps Compliance Corp in Q4 2021 and held it in 2 quarters.
- Raymond James & Associates's Sharps Compliance Corp position peaked at $842K in Q4 2021.
- 67 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2022.
Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.